Nuvation Bio NUVB Increase (Decrease) in Interest and Dividends Receivable
Increase (Decrease) in Interest and Dividends Receivable at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable.
The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's increase (decrease) in interest and dividends receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's increase (decrease) in interest and dividends receivable?
- Nuvation Bio (NUVB) reported increase (decrease) in interest and dividends receivable of -$24K in Q1 2026.
- How has Nuvation Bio's increase (decrease) in interest and dividends receivable changed year-over-year?
- Nuvation Bio's increase (decrease) in interest and dividends receivable decreased by 101.6% year-over-year, from $1.48M to -$24K.
- What is the long-term trend for Nuvation Bio's increase (decrease) in interest and dividends receivable?
- Over 3 years (2021 to 2025), Nuvation Bio's increase (decrease) in interest and dividends receivable has grown at a -48.9% compound annual growth rate (CAGR), from $2.13M to -$285K.
- What does increase (decrease) in interest and dividends receivable mean?
- Reflects the change in accrued interest or dividend income that has been earned but not yet received in cash. This adjustment is necessary to align net income with actual cash inflows from investment activities.